Clinical Trial Update: A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating atorvastatin in hyperlipidemic patients, focusing on LDL-cholesterol outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED